Login / Signup

Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'.

Siddharth JainArghya Chattopadhyay
Published in: Annals of the rheumatic diseases (2021)
Keyphrases
  • rheumatoid arthritis
  • study protocol
  • phase iii
  • clinical trial
  • high dose
  • disease activity
  • phase ii
  • randomized controlled trial
  • stem cells
  • mesenchymal stem cells
  • bone marrow